Connect with us

Latest News

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Published

on

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Infosys, a global leader in next-generation digital services and consulting, has announced a strategic investment of INR 8.3 crore (approximately $1 million) in 4baseCare, a promising healthcare deep-tech firm specializing in precision oncology solutions. This investment underscores Infosys’ commitment to leveraging cutting-edge technologies to address critical healthcare challenges.

About 4baseCare

Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare focuses on utilizing advanced genomics and clinical data to personalize cancer treatment. The firm employs AI and analytics to improve cancer diagnosis, treatment, and drug discovery. Their unique approach includes the development of comprehensive genomic panels that enable oncologists to select optimal targeted therapies for patients.

Precision Oncology Solutions

4baseCare’s precision oncology solutions are designed to:

  • Enhance Cancer Diagnosis: By integrating diverse genomic data, the platform allows for more accurate identification of cancer types and stages.
  • Personalize Treatment Plans: Utilizing AI-driven insights, the startup aims to tailor treatment strategies based on individual patient profiles.
  • Accelerate Drug Discovery: The data-driven approach helps streamline the development of new cancer therapies.

Strategic Alignment with Infosys

Infosys’ investment in 4baseCare aligns with its broader strategy to foster innovation and drive digital transformation within the healthcare industry. By partnering with 4baseCare, Infosys aims to enhance its offerings and provide advanced solutions to its clients in the healthcare and life sciences sectors.

Expected Benefits of the Investment

The investment will enable Infosys to tap into 4baseCare’s expertise in precision oncology, allowing it to:

  • Develop innovative healthcare solutions that can improve patient outcomes.
  • Leverage advanced analytics to reduce healthcare costs through more effective treatments.
  • Enhance its portfolio of services aimed at healthcare providers and institutions.

Future Prospects

This strategic move comes at a time when the Indian healthtech startup ecosystem is gaining momentum. Despite facing challenges in fundraising—having raised only $7 billion across 886 deals from 2014 to mid-2024—the sector is witnessing increased interest from investors seeking innovative solutions to pressing healthcare issues.

In recent months, 4baseCare has also made headlines by raising $6 million in its Series A funding round led by Yali Capital, demonstrating strong investor confidence in its potential.

Conclusion

Infosys’ investment in 4baseCare represents a significant step toward enhancing its capabilities in the healthcare sector, particularly in precision oncology. By combining Infosys’ technological prowess with 4baseCare’s innovative solutions, this partnership is poised to make a meaningful impact on cancer treatment and patient care. As both companies work together to advance healthcare technology, they are likely to contribute significantly to improving health outcomes and driving efficiencies within the industry.

Continue Reading
Advertisement
1 Comment

1 Comment

  1. droversointeru

    April 12, 2025 at 8:58 pm

    Nice read, I just passed this onto a friend who was doing a little research on that. And he just bought me lunch as I found it for him smile Thus let me rephrase that: Thank you for lunch!

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Blissclub Raises INR 33 Crore in Fresh Funding Months After Layoffs

Published

on

Bliss_StartupStories

Blissclub, the women-centric D2C apparel brand, has raised INR 33 crore in a Pre-Series B funding round led by Elevation Capital, with Eight Roads Ventures also participating. This funding comes just three months after the company laid off 18% of its workforce-about 21 employees from creative, sales, marketing, growth, and product teams-due to high cash burn and challenges in securing new capital.

The latest investment was made through the allotment of 16,076 compulsory convertible preference shares (CCPS) at a premium of INR 20,428 each. Elevation Capital invested INR 19 crore, securing a 24.5% stake, while Eight Roads Ventures contributed INR 14 crore, raising its stake to 15.79%. The capital will be used for working capital, capital expenditure, and general corporate purposes.

Founded in 2020 by Minu Margeret, Blissclub started as an online activewear brand for women and has since diversified its product range and established offline stores. Despite recent restructuring, the company’s revenue grew 27% to INR 86.9 crore in FY24 from INR 68.3 crore in FY23, though net losses also increased to INR 43.9 crore.

Blissclub’s successful fundraising, despite recent layoffs, underscores both the ongoing challenges and the resilience of India’s D2C startup sector in a difficult funding environment.

 

Continue Reading

Latest News

Apple to Shift Entire US iPhone Assembly to India by 2026

Published

on

Apple - StartupStories

Apple is set to relocate all assembly of iPhones destined for the US market from China to India by the end of 2026, marking its biggest manufacturing shift in decades. The move is driven by escalating US-China trade tensions and steep tariffs—up to 145% on Chinese imports—making Chinese assembly increasingly costly for Apple. Although some smartphone imports are temporarily exempt, a 20% duty still applies to Chinese-made iPhones entering the US.

 

India, in contrast, offers a more favorable trade environment, with a paused 26% reciprocal tariff and ongoing negotiations for a bilateral trade deal with the US that could shield Indian exports from future levies. Apple plans to more than double its current iPhone output in India, aiming to assemble over 60 million units annually for the US market. The company already produces about 25% of its global iPhones in India, working with partners like Foxconn, Tata Electronics, and Pegatron.

 

This shift is part of Apple’s broader strategy to diversify its supply chain and reduce reliance on China amid geopolitical risks. However, the transition’s success will depend on how quickly India can scale up its manufacturing capabilities and the outcome of ongoing trade negotiations.


Continue Reading

Latest News

PhonePe’s PINCODE Launches 10-Minute Medicine Delivery in Cities

Published

on

PhonePe

PhonePe’s PINCODE app has launched a 24×7 online medicine delivery service in Bangalore, Mumbai, and Pune, promising delivery of both prescription and over-the-counter medicines within 10 minutes from nearby local medical shops. Unlike conventional e-pharmacies that use dark stores, PINCODE partners exclusively with neighborhood pharmacies, enabling faster deliveries and supporting local businesses in the digital economy.

Customers without prescriptions can select a “no prescription” option when ordering; a qualified doctor then provides a free teleconsultation and issues a digital prescription compliant with telemedicine guidelines, ensuring seamless access to medicines. The app offers competitive pricing by passing discounts from local pharmacies directly to customers and charges no delivery fees.

PINCODE’s hyperlocal model enhances healthcare accessibility and convenience while empowering local pharmacies, helping them remain integral to their communities and stimulating local economic growth. Launched in 2023, the app focuses on quick commerce with an emphasis on speed, reliability, and supporting local sellers.

In summary, PhonePe’s PINCODE app is transforming medicine delivery in major Indian cities by combining ultra-fast 10-minute delivery, free doctor consultations, and a hyperlocal sourcing model that benefits both consumers and neighborhood pharmacies.

Continue Reading
Advertisement

Recent Posts

Advertisement